908 Devices (MASS) Depreciation & Amortization (CF) (2020 - 2026)

908 Devices' (MASS) quarterly Depreciation & Amortization (CF) came in at $1.1 million in Q1 2026, down 11.77% year-on-year from $1.3 million in Q1 2025, and up 2.52% on a QoQ basis from $1.1 million in Q4 2025.

908 Devices (MASS) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

908 Devices (MASS) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $1.1 million in Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 11.77% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $4.3 million, a 7.15% decrease from a year earlier, with the FY2025 full-year figure at $4.5 million, down 4.63% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $1.1 million, up from $1.1 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for MASS reached as high as $1.4 million in Q4 2024 and fell as low as $267000.0 in Q1 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $840235.3 across 5 years, with a median of $740000.0 in 2023.
  • Across the five-year window, Depreciation & Amortization (CF) declined 29.81% in 2023 and jumped 254.81% in 2024, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $577000.0 in 2022, then declined by 29.81% to $405000.0 in 2023, then soared by 254.81% to $1.4 million in 2024, then retreated by 22.69% to $1.1 million in 2025, then grew by 2.52% to $1.1 million in 2026.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 183.95 Bn 176.66 Bn 6.27 Bn 381.00 Mn
2 Stryker 128.83 Bn 125.95 Bn 3.81 Bn 120.00 Mn
3 Medtronic 108.81 Bn 99.59 Bn 6.41 Bn 716.00 Mn
4 Boston Scientific 68.39 Bn 66.94 Bn 3.61 Bn 351.00 Mn
5 Edwards Lifesciences 48.28 Bn 44.60 Bn 1.29 Bn 40.90 Mn
6 Dexcom 28.39 Bn 27.27 Bn 750.30 Mn 67.10 Mn
7 GE HealthCare Technologies 28.30 Bn 26.01 Bn 1.98 Bn 78.00 Mn
8 Smith & Nephew 26.95 Bn 26.37 Bn - -
9 Koninklijke Philips 25.45 Bn 22.32 Bn 2.07 Bn 310.25 Mn
10 908 Devices 259.57 Mn 147.83 Mn 6.88 Mn 1.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.14 Mn
Mar 31, 2026 1.14 Mn
Dec 31, 2025 1.11 Mn
Dec 31, 2025 1.11 Mn
Sep 30, 2025 1.09 Mn
Sep 30, 2025 1.09 Mn
Jun 30, 2025 972,000.00
Jun 30, 2025 972,000.00
Mar 31, 2025 1.29 Mn
Mar 31, 2025 1.29 Mn
Dec 31, 2024 1.44 Mn
Dec 31, 2024 1.44 Mn
Sep 30, 2024 1.41 Mn
Sep 30, 2024 1.41 Mn
Jun 30, 2024 504,000.00
Jun 30, 2024 504,000.00
Mar 31, 2024 1.33 Mn
Mar 31, 2024 1.33 Mn
Dec 31, 2023 405,000.00
Dec 31, 2023 405,000.00